Publications by authors named "S Tyciakova"

A promising approach to treat colorectal cancer (CRC) involves combining chemotherapy, epigenetics, and gene therapy to combat drug resistance. Multifunctional nanocarriers have emerged as a valuable tool for targeted CRC therapy. By delivering multiple treatments directly to cancer cells, these nanocarriers offer the potential for improved outcomes and reduced side effects.

View Article and Find Full Text PDF

Cancer is one of the leading causes of death worldwide. We still do not understand all the details of carcinogenesis, and effective treatment is lacking for many oncological diseases. Animal models provide an irreplaceable tool to observe the growth and spreading of neoplastic cells in an environment of living organisms, to test the efficacy of cancer treatment, side effects, and toxicity, and to study the tumor microenvironment.

View Article and Find Full Text PDF
Article Synopsis
  • Decitabine (DAC) is a drug that helps treat solid tumors, but more research is needed to understand how safe and effective it is.
  • Researchers tried using DAC with breast cancer cells to see if a special protein called DCK could make DAC work better, but it didn't change the DNA levels or kill more cancer cells.
  • DAC caused some genes to become more or less active in the cells, showing that it can change how cancer cells behave, but some bad genes were still active, which could make treatment harder.
View Article and Find Full Text PDF

Background: Tumor necrosis factor alpha (TNFα) is a pleiotropic cytokine with both anti-tumorigenic and pro-tumorigenic activity, affecting tumor cell biology, the balance between cell survival and death. The final effect of TNFα is dependent on the type of malignant cells, with the potential to arrest cancer progression.

Methods: In order to explain the diverse cellular response to TNFα, we engineered melanoma and colorectal carcinoma cell lines stably overexpressing this cytokine.

View Article and Find Full Text PDF

We report results showing that the silencing of carbonic anhydrase I (siCA1) in prostatic (PC3) tumour cells has a significant impact on exosome formation. An increased diameter, concentration and diversity of the produced exosomes were noticed as a consequence of this knock-down. The protein composition of the exosomes' cargo was also altered.

View Article and Find Full Text PDF